Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Michael, Kennelly"'
Autor:
Andreas Willumsen, Tabasum Reza, Lars Schertiger, Per Bagi, Michael Kennelly, Lene Feldskov Nielsen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Intermittent catheterization (IC) utilizing conventional eyelets catheters (CECs) for bladder drainage has long been the standard of care. However, when the tissue of the lower urinary tract comes in close proximity to the eyelets, mucosal s
Externí odkaz:
https://doaj.org/article/e11fceac15dd42dea6d7d1afee925b9f
Autor:
Alison Demarco McRae, Michael Kennelly
Publikováno v:
Continence, Vol 7, Iss , Pp 100712- (2023)
Objectives:: The PureWick™ female external catheter provides a non-invasive method to manage female urinary incontinence, measure urinary output, and reduce skin breakdown from urinary incontinence. This study seeks to expand the limited clinical e
Externí odkaz:
https://doaj.org/article/6bbc20685a8547cd9d467eb4f377ccce
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Background: Few randomized controlled trials evaluate the long-term efficacy and safety of pharmacotherapy for overactive bladder (OAB). This network meta-analysis compares the long-term (52-week) efficacy and safety of vibegron, mirabegron and antic
Externí odkaz:
https://doaj.org/article/38234546bf3741fa8c2a5ff92b695a47
Autor:
Matthias Walter, Michel Wyndaele, Veronique Keppenne, Desiree Vrijens, Marcio A. Averbeck, Charalampos Konstantinidis, Blayne Welk, Jean-Jacques Wyndaele, Michael Kennelly, Véronique Phé, Susanne Vahr Lauridsen, Jürgen Pannek, Thomas M. Kessler, Harvinder S. Chhabra, Francois Theron, Tom E. Nightingale, Andrei V. Krassioukov
Publikováno v:
Continence, Vol 4, Iss , Pp 100566- (2022)
Externí odkaz:
https://doaj.org/article/b7c18e2cf3b746c2a63cf1daf08e5583
Autor:
David Staskin, Jeffrey Frankel, Susann Varano, Michael Kennelly, Diane K. Newman, Matt T. Rosenberg, Denise D. Shortino, Rachael A. Jankowich, Paul N. Mudd Jr
Publikováno v:
International Journal of Clinical Practice, Vol 2022 (2022)
Background. Overactive bladder (OAB) is characterized by urgency and frequency with (OAB wet) or without (OAB dry) urge urinary incontinence (UUI). In the phase 3 EMPOWUR trial, vibegron—a selective β3-adrenergic receptor agonist for the treatment
Externí odkaz:
https://doaj.org/article/a1208647e958488387dc535f657fb93d
Publikováno v:
Urogynecology. 29:452-457
Autor:
Blayne Welk, Michael Kennelly
Publikováno v:
Neurourology and Urodynamics. 41:1451-1457
Adult nocturnal enuresis (NE) is an understudied and bothersome condition. Our objective was to conduct a conjoint analysis experiment to better understand the relative importance of NE consequences in older women.We developed a conjoint analysis sur
Publikováno v:
Journal of Urology. 209
Autor:
Michael Kennelly, Nikesh Thiruchelvam, Márcio Augusto Averbeck, Charalampos Konstatinidis, Emmanuel Chartier-Kastler, Pernille Trøjgaard, Rikke Vaabengaard, Andrei Krassioukov, Birte Petersen Jakobsen
Publikováno v:
Advances in Urology, Vol 2019 (2019)
A risk factor model for urinary tract infections in patients with adult neurogenic lower urinary tract dysfunction performing clean intermittent catheterisation was developed; it consists of four domains, namely, (1) general (systemic) conditions in
Externí odkaz:
https://doaj.org/article/825bb522159f4f59aeafacc14d7bcc8f
Autor:
Pierre, Denys, Juan Carlos, Castaño Botero, Ricardo Luis, Vita Nunes, Barton, Wachs, Cristiano, Mendes Gomes, Grigory, Krivoborodov, Le Mai, Tu, Giulio, Del-Popolo, Catherine, Thompson, Claire, Vilain, Magali, Volteau, Michael, Kennelly
Publikováno v:
Neurourology and urodynamicsREFERENCES. 42(1)
Neurogenic detrusor overactivity incontinence (NDOI) is often inadequately managed with oral therapy.To assess efficacy and safety of abobotulinumtoxinA (aboBoNT-A; Dysport®; Ipsen Ltd.) according to etiology of NDOI.Two phase III, randomized, doubl